T1	Participants 87 101	southern Ghana
T2	Participants 246 295	peri-urban community (Ashaiman) in southern Ghana
T3	Participants 560 610	in children under 5 years of age in the study area
T4	Participants 777 896	2% (8/399) to 2.3% (9/385) of the acellular vaccine recipients as against 31% (122/394) in the whole-cell vaccine group
